Opportunity Information: Apply for PAR 19 310

The Behavioral Science Track Award for Rapid Transition (B/START) (R03 Clinical Trial Optional) is a National Institute on Drug Abuse (NIDA) funding opportunity that uses the NIH Small Research Grant (R03) mechanism to support early-stage, targeted projects that bring affective, cognitive, and behavioral science approaches to key questions in substance use disorders (SUD). The central purpose is to seed innovative ideas, hypotheses, models, and methods that can move the behavioral science of addiction forward, whether the work is preclinical (for example, lab-based or animal model research that informs mechanisms) or clinical (for example, studies involving people, including clinical trials if the applicant chooses to propose one). In practical terms, this opportunity is designed for smaller, faster projects that can generate credible preliminary findings and help investigators transition to larger NIH applications later.

A defining feature of B/START is its emphasis on generating a coherent set of pilot or preliminary results that directly set up the next step in a research trajectory. NIDA is looking for studies that do more than just explore an idea in a loose way; the expectation is that the project will produce data that can inform the design of a larger, more complete investigation and provide feasibility evidence or scientific rationale for a subsequent R01, R21, or similar grant. Because of that, strong applications are typically framed around clear, testable behavioral science questions tied to SUD, paired with methods that can realistically be completed within the limited R03 scope while still yielding interpretable outcomes.

The target investigator audience includes two main groups. First, recently independent investigators who already have behavioral science expertise and are poised to apply it to substance use disorder research. Second, established investigators who are new to applying behavioral science approaches in the SUD space and want to pivot or expand their work into addiction-related questions. This structure reflects the program's goal of bringing new behavioral science talent and perspectives into SUD research while also supporting early independence and rapid proof-of-concept work.

The opportunity is listed as "Clinical Trial Optional," which means applicants may propose a clinical trial if it fits the aims, but they are not required to do so. This allows for flexibility across a wide range of behavioral science projects, including mechanistic studies of decision-making or emotion regulation in the context of substance use, development or refinement of behavioral tasks or paradigms, early tests of interventions grounded in cognitive or affective theory, or studies that validate new behavioral measures relevant to addiction risk, craving, withdrawal, relapse, or treatment engagement.

In terms of applicant eligibility, the program is broadly open to many types of U.S.-based organizations, reflecting typical NIH eligibility rules for research grants. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other eligible entities. The notice also explicitly highlights categories often associated with broadening participation and capacity, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

Foreign participation is explicitly restricted. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible to apply, and foreign components, as defined by the NIH Grants Policy Statement, are not allowed. The practical implication is that the applicant organization and the supported work must be situated within allowable U.S.-based institutional structures without foreign components as part of the proposed project.

From the source details provided, the funding opportunity title is "Behavioral Science Track Award for Rapid Transition (B/Start) (R03 Clinical Trial Optional)" with opportunity number PAR 19 310. It is a discretionary grant under NIH, with a funding activity category in education and health and a CFDA number of 93.279. The award ceiling listed is $75,000. The original closing date shown is 2022-01-07, and the creation date is 2019-06-28. Overall, the program is best understood as a small, focused NIDA entry point for behavioral scientists to produce fundable preliminary evidence and accelerate progression to larger-scale addiction research funding.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2019-06-28.
  • Applicants must submit their applications by 2022-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $75,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 19 310

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)

Previous opportunity: Enabling Technologies to Accelerate Development of Oral Biodevices (R41/R42 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 19 310

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 19 310) also looked into and applied for these:

Funding Opportunity
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 - Clinical Trials Not Allowed) Apply for RFA DA 20 006

Funding Number: RFA DA 20 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed) Apply for RFA DA 20 007

Funding Number: RFA DA 20 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed) Apply for RFA DA 20 023

Funding Number: RFA DA 20 023
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) Apply for RFA CA 19 057

Funding Number: RFA CA 19 057
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional) Apply for PAR 19 318

Funding Number: PAR 19 318
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) Apply for RFA CA 19 045

Funding Number: RFA CA 19 045
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $2,500,000
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 19 046

Funding Number: RFA CA 19 046
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Apply for PAR 19 325

Funding Number: PAR 19 325
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Palliative Care in Home and Community Settings (R21 Clinical Trial Optional) Apply for PAR 19 320

Funding Number: PAR 19 320
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional) Apply for PAR 19 326

Funding Number: PAR 19 326
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Palliative Care in Home and Community Settings (R01 Clinical Trial Optional) Apply for PAR 19 321

Funding Number: PAR 19 321
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) Apply for PAR 19 327

Funding Number: PAR 19 327
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional) Apply for RFA HL 20 016

Funding Number: RFA HL 20 016
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Apply for PAR 19 340

Funding Number: PAR 19 340
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Apply for PAR 19 339

Funding Number: PAR 19 339
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) Apply for PAR 19 349

Funding Number: PAR 19 349
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) Apply for PAR 19 345

Funding Number: PAR 19 345
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Apply for PAR 19 348

Funding Number: PAR 19 348
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Apply for PAR 19 350

Funding Number: PAR 19 350
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Apply for PAR 19 356

Funding Number: PAR 19 356
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 310", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: